Company / Tangible Book Value per Share
West Pharmaceutical Services Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$42.41
FY2025
5-year range
$19.76 / $42.41
FY2021-FY2025
Trend
+21.0%
vs FY2024
Sector context
#12 of 158
Health Care
What the data says
Among 158 Health Care companies, West Pharmaceutical Services is in the top 8% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $11.79 in FY2016 to $42.41 in FY2025.
Based on SEC 10-K filings.
42.41 in FY2025 with a 5-year CAGR of +19.5%. Top quartile in the Health Care sector.
Improved from $37.42 to $42.41 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +21.7%
- 5-Year CAGR
- +19.5%
- 10-Year CAGR
- -
Sector benchmark
+129.6% above sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 21.0% year-over-year.
- Ranks #12 out of 158 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.41 | +21.0% |
| FY2024 | $35.05 | -6.3% |
| FY2023 | $37.42 | +59.1% |
| FY2022 | $23.51 | +19.0% |
| FY2021 | $19.76 | +13.6% |
| FY2020 | $17.39 | -12.1% |
| FY2019 | $19.78 | +13.2% |
| FY2018 | $17.46 | +8.9% |
| FY2017 | $16.04 | +36.0% |
| FY2016 | $11.79 | +5.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026